For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Overview of Global Fluralaner market:
According to our latest research, the global Fluralaner market looks promising in the next 5 years. As of 2022, the global Fluralaner market was estimated at USD 21.9 million, and it's anticipated to reach USD 36.12 million in 2028, with a CAGR of 8.7% during the forecast years.
Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits ?-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide).
Fluralaner has promise in the pet market
In recent years, there has been a general trend of buying pets in the whole society. For example, the percentage of the population that owns a pet jumped from 56 percent in 1988 to 67 percent in 2020, according to a survey by the American Pet Products Association (APPA). Dogs remained the most popular domestic animal (63.4%), followed by cats (42.7%), freshwater fish (11.5%) and birds (5.7%). The relationship between pets and their owners is growing day by day, and many families consider pets as family members. The way pets are treated has also changed due to the growing bond between animals and their owners, suggesting an increased humanization of pets. As a result, the demand for high-quality pet products has increased. According to the American Pet Products Association's (APPA) 2020 State of the Industry report, pet industry sales surpassed $100 billion for the first time. Hence, the demand for products for pets has increased.
The U.S. Food and Drug Administration (FDA) approved it under the trade name RAVECTO® (fluralaner) for flea treatment in dogs in May 2014 and RAVECTO® (fluralaner) Plus as a topical treatment for cats in November 2019. The EU approved the drug in February 2014. Australia approved it for the treatment and prevention of ticks and fleas on dogs in January 2015. Fluralaner products are used to help pets grow up healthier. Therefore, there is an increasing demand for higher quality Fluralaner products.
Region Overview:
In 2021, the Production share of the Fluralaner market in Japan stood at 71.14%.
Company Overview:
The major players operating in the Fluralaner market include Nissan Chemical Corporation, Hikal Ltd., Dideu Group, Masteam Bio-tech (Wuhan) Co.,Ltd., Rivocean Jiangsu Pharmaceutical Co., Ltd., etc. Among which, Nissan Chemical Corporation ranked top in terms of sales and revenue in 2022.
Nissan Chemical Corp (Nissan Chemical) is a chemical company that develops, manufactures and sells display, semiconductor and inorganic materials; herbicides, insecticides and fungicides; and basic and high-purity chemicals. The company conducts custom manufacturing, and provides process research services for pharmaceutical ingredients and intermediates from pre-clinical to commercial production stages.
Hikal offers solutions across the life sciences value chain. Hikal provide world-class active ingredients, intermediates and R&D services to global pharmaceuticals, animal health, biotech, crop protection and specialty chemicals companies.
Segmentation Overview:
Among different product types, Purity ? 99% segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Oral Drug segment occupied the biggest share from 2017 to 2022.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Fluralaner market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.
Key Takeaways from the Global Fluralaner Market Report:
Market Size Estimates: Fluralaner market size estimation in terms of value and sales volume from 2018-2028
Market Trends and Dynamics: Fluralaner market drivers, opportunities, challenges, and risks
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Fluralaner market
Segment Market Analysis: Fluralaner market value and sales volume by type and by application from 2018-2028
Regional Market Analysis: Fluralaner market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa
Country-level Studies on the Fluralaner Market: Revenue and sales volume of major countries in each region
Fluralaner Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.
Trade Flow: Import and export volume of the Fluralaner market in major regions.
Fluralaner Industry Value Chain: Fluralaner market raw materials & suppliers, manufacturing process, distributors, downstream customers
Fluralaner Industry News, Policies & Regulations
Key players in the global Fluralaner market are covered in Chapter 12:
Nissan Chemical Corporation
Rivocean Jiangsu Pharmaceutical Co., Ltd.
Gihi chemicals Co., Limited.
Hikal Ltd.
Dideu Group
Masteam Bio-tech (Wuhan) Co.,Ltd.
In Chapter 2 and Chapter 15.1, based on types, the Fluralaner market from 2018 to 2028 is primarily split into:
Purity ? 98%
Purity ? 99%
In Chapter 3 and Chapter 15.2, based on applications, the Fluralaner market from 2018 to 2028 covers:
Oral Drug
Topical Drug
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:
North America (Covered in Chapter 7)
United States
Canada
Asia-Pacific (Covered in Chapter 8)
China
Japan
India
South Korea
Southeast Asia
Australia
Others
Europe (Covered in Chapter 9)
Germany
France
UK
Italy
Spain
Russia
Poland
Others
Latin America (Covered in Chapter 10)
Mexico
Brazil
Argentina
Others
Middle East and Africa (Covered in Chapter 11)
GCC Countries
Africa
Others
The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.
In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.
Chapter Outline
This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 starts the report with an overview of the Fluralaner market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.
Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.
Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.
Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.
Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.
Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.
Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.
Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.
Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.
Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.
Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.
Years considered for this report:
Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028